Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-002352

Options or other derivatives

  • CFO and Treasurer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Krognes Steve E. CFO and Treasurer 2021-01-04 Grant or award · Restricted Stock Units +30,000 30,000 D
Krognes Steve E. CFO and Treasurer 2021-01-04 Grant or award · Stock Option (right to buy) +90,000 90,000 D
Loading xslF345X03/doc4.xml…